PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
+9.27%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$751M
AUM Growth
+$241M
(+47%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
21.16%
Top 10 Holdings %
Top 10 Hldgs %
38.08%
Holding
168
New
36
Increased
30
Reduced
20
Closed
26
Top Buys
| 1 |
Cooper Companies
COO
|
$27M |
| 2 |
PPD
PPD, Inc. Common Stock
PPD
|
$22.2M |
| 3 |
Outset Medical
OM
|
$17M |
| 4 |
Vericel Corp
VCEL
|
$16.7M |
| 5 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$15.9M |
Top Sells
| 1 |
Inspire Medical Systems
INSP
|
$9.96M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
$9.32M |
| 3 |
LivaNova
LIVN
|
$7.29M |
| 4 |
Boston Scientific
BSX
|
$6.44M |
| 5 |
OraSure Technologies
OSUR
|
$5.65M |
Sector Composition
| 1 | Healthcare | 81.75% |
| 2 | Industrials | 1.96% |
| 3 | Consumer Staples | 1.16% |
| 4 | Energy | 0.64% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DexCom
DXCM
$31.6B
| $10.6M | 0.55% |
102,732
+4,800
| +5% | +$495K |
|
27
Pacific Biosciences
PACB
$381M
| $9.87M | 0.51% |
+1,000,000
| New | +$9.87M |
|
28
10x Genomics
TXG
$1.74B
| $9.32M | 0.48% |
74,720
+30,800
| +70% | +$3.84M |
|
|
IMMU
29
DELISTED
Immunomedics Inc
IMMU
| $8.5M | 0.44% |
100,000
-45,445
| -31% | -$3.86M |
|
|
IMDX
30
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71M
| $8.37M | 0.43% |
301,127
+1,941
| +0.6% | +$54K |
|
31
Guardant Health
GH
$7.5B
| $8.28M | 0.43% |
74,092
+11,192
| +18% | +$1.25M |
|
32
OrthoPediatrics
KIDS
$524M
| $8.19M | 0.42% |
178,418
+6,305
| +4% | +$290K |
|
|
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.99M | 0.36% |
+90,000
| New | +$6.99M |
|
|
SILK
34
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.95M | 0.36% |
103,400
-15,500
| -13% | -$1.04M |
|
35
Laird Superfood
LSF
$61.3M
| $6.88M | 0.35% |
+150,000
| New | +$6.88M |
|
|
OTIC
36
DELISTED
Otonomy, Inc.
OTIC
| $6.77M | 0.35% |
1,671,748
+424,890
| +34% | +$1.72M |
|
37
Standard BioTools
LAB
$497M
| $6.04M | 0.31% |
812,757
-31,543
| -4% | -$234K |
|
|
MSON
38
DELISTED
Misonix Inc
MSON
| $5.76M | 0.3% |
490,586
+127,000
| +35% | +$1.49M |
|
39
Immunovant
IMVT
$2.99B
| $5.6M | 0.29% |
159,026
-111,780
| -41% | -$3.93M |
|
|
NVTA
40
DELISTED
Invitae Corporation
NVTA
| $5.29M | 0.27% |
122,000
-18,900
| -13% | -$819K |
|
41
Bristol-Myers Squibb
BMY
$96B
| $5.27M | 0.27% |
+87,469
| New | +$5.27M |
|
42
Schrodinger
SDGR
$1.41B
| $5.11M | 0.26% |
+107,500
| New | +$5.11M |
|
43
Quanterix
QTRX
$211M
| $5.1M | 0.26% |
+151,175
| New | +$5.1M |
|
|
DMTK
44
DELISTED
DermTech, Inc. Common Stock
DMTK
| $4.81M | 0.25% |
402,718
-68,425
| -15% | -$818K |
|
45
Haemonetics
HAE
$2.62B
| $4.8M | 0.25% |
+55,000
| New | +$4.8M |
|
|
LHCG
46
DELISTED
LHC Group LLC
LHCG
| $4.78M | 0.25% |
22,497
-43,862
| -66% | -$9.32M |
|
47
TELA Bio
TELA
$63M
| $4.77M | 0.25% |
+288,605
| New | +$4.77M |
|
|
NARI
48
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $4.66M | 0.24% |
67,500
+10,375
| +18% | +$716K |
|
49
BioLife Solutions
BLFS
$1.27B
| $4.49M | 0.23% |
+155,000
| New | +$4.49M |
|
|
TRIL
50
DELISTED
Trillium Therapeutics Inc.
TRIL
| $4.47M | 0.23% |
314,487
+215,700
| +218% | +$3.07M |
|